Trials / Unknown
UnknownNCT03332849
Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
A Phase 1, Multiple Ascending Dose Glucose Clamp Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 in Comparison to Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Mellitus
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 1 multiple ascending dose (MAD) study, conducted in subjects with Type 1 and Type 2 diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HM12470 | HM12470 is a long-acting insulin analogue |
Timeline
- Start date
- 2015-07-28
- Primary completion
- 2018-04-30
- Completion
- 2018-04-30
- First posted
- 2017-11-06
- Last updated
- 2017-11-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03332849. Inclusion in this directory is not an endorsement.